규제 업데이트
2026년 9월 10일•1분 읽기
FDA Approves TRANSDERM SCOP (NDA017874) Transdermal Scopolamine Patch
The FDA has approved the prescription transdermal patch TRANSDERM SCOP, containing 1 mg scopolamine per 72 hr, under NDA 017874. Baxter Healthcare is the manufacturer.
규제 업데이트
2026년 9월 3일•1분 읽기
FDA Approves ANDA210272 for Buprenorphine Transdermal Patch
The FDA has approved application ANDA210272 for a buprenorphine transdermal patch, covering five dosage strengths and requiring a REMS program.